Tolvaptan efficacy and drug-drug interactions
- 1 September 2020
- journal article
- letter
- Published by Edizioni Minerva Medica in Minerva Endocrinology
- Vol. 45 (3) , 264-265
Abstract
Article: Tolvaptan efficacy and drug-drug interactions - Minerva Endocrinologica 2020 September;45(3):264-5 - Minerva Medica - JournalsKeywords
This publication has 5 references indexed in Scilit:
- Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel RecommendationsThe American Journal of Medicine, 2013
- The Use of Vaptans in Clinical EndocrinologyThe Journal of Clinical Endocrinology & Metabolism, 2013
- Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non‐peptide AVP antagonist in healthy subjectsBritish Journal of Clinical Pharmacology, 2012
- Hyponatremia in patients with infectious diseasesJournal of Infection, 2011
- Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2009